Sociedad Española de Terapia Génica y Celular
  • Home
  • Policies & advocacy
    • Policies & advocacy
    • Regulatory information
      • GMP Guidelines
    • EMA guidance
    • ESGCT statements
    • Useful links
Home

This week in gene and cell therapy - 13 July 2018

Gene and cell therapy headlines 9 - 13 July


Axovant announces licensing of Benitec Silence and Replace and plans for 2019 oculopharyngeal muscular dystrophy clinical trial

Non-cutting CRISPRa used to create iPS cells from fibroblasts

Lysine derivative developed as an in vivo off switch for CRISPR/Cas

FGF21 gene therapy for diabetes type 2 successful in mice

Gene editing effective for controlling cholesterol in primates

Pluristem Therapeutics and Thermo Fisher Scientific announce partnership to scale up cell
 

Account login

Create a secure accountJoin
Forgotten your details?

Sponsors

Diamond

Platinum

Gold

Silver

Bronze

Copyright © 2023 Sociedad Española de Terapia Génica y Celular Member Area Terms and Conditions user account Privacy Policy Cookies Terms and Conditions membership purchase Terms and Conditions congress registration Terms and Conditions abstract submission Terms and Conditions user account RSS feed Join us Follow us